Revive Therapeutics Ltd (RVVTF)

[Hattrick3]

Not sure why the write ups on VERU are so bullish. They were at or around 55% efficacy on 204 moderate to severe patients and that is with an extremely high death rate on the placebo side. They have the only trial I know of where hospitalized patients had a placebo death rate of 35%! We would have had an EUA done and in the books already with a death rate of half of that. That will be tough to explain to the FDA. A sample of 204 is crazy low for an EUA. It has to be nothing but great news for Bucillamine’s chances if the FDA let’s them through.